PREDICTORS OF AND SATISFACTION WITH BILATERAL PROPHYLACTIC MASTECTOMY

被引:128
作者
STEFANEK, ME
HELZLSOUER, KJ
WILCOX, PM
HOUN, F
机构
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21218
[3] US FDA,DIV MAMMOG QUAL,ROCKVILLE,MD 20857
[4] US FDA,RADIAT PROGRAM,ROCKVILLE,MD 20857
关键词
D O I
10.1006/pmed.1995.1066
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Women with a first-degree relative with breast cancer are at increased risk of developing this disease. The optimal medical management of these women is unclear, with options including close breast cancer screening, bilateral prophylactic mastectomy, or participation in chemoprevention trials. Among women who undergo prophylactic bilateral mastectomy, very little is known about satisfaction with this surgery. Also, we know very little about variables related to prophylactic mastectomy decision making. Methods. Participants were women at increased risk of breast cancer due to family history. These women were categorized by self-report as not interested in prophylactic mastectomy (n = 58), interested but deciding against surgery (n = 92), or subsequently having a bilateral prophylactic mastectomy (n = 14). Information on screening practices, risk. perception, level of depression, and cancer-related worry was collected. Women completing prophylactic mastectomy reported on their satisfaction with the surgery and breast reconstruction. Results. Women selecting surgery reported more breast cancer worry. The group expressing no interest in surgery reported fewer biopsies and lower risk estimates. Women completing surgery were satisfied with their decision, although satisfaction with reconstruction was mixed. Conclusion. Factors influencing surgical decision making may include breast-cancer-related worry, biopsy history, and subjective breast cancer risk. (C) 1995 Academic Press, Inc.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 29 条
[1]  
Hall J.M., Lee M.K., Newman B., Et al., Linkage of early onset breast cancer to chromosome 17q21, Science, 250, pp. 1684-1689, (1990)
[2]  
King M.-C., Rowell S., Love S.M., Inherited breast cancer and ovarian cancer: What are the risks? What are the choices?, JAMA, 269, pp. 1975-1980, (1993)
[3]  
Houn F., Helzlsouer K., Friedman N., Stefanek M., Prophylactic mastectomy: A survey of Maryland surgeons, Am J Public Health
[4]  
Stout H., Radical gambit
[5]  
some healthy women undergo mastectomies to avert breast cancer, Wall Street J, 11, (1992)
[6]  
Brody J.E., Why cancer-free women have breasts removed, NY Times, 5, (1993)
[7]  
NSABP Protocol P-l, A Clinical Trial to Determine the Worth of Tamoxifen for Preventing Breast Cancer, (1992)
[8]  
Temple W.J., Lindsay R.L., Magi E., Urbanski S.J., Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer, Am J Surg, 161, pp. 413-415, (1991)
[9]  
Dowden R.V., Grundfest-Broniatowski S., Prophylactic mastectomy: When and how?, Controversies in Breast Disease: Diagnosis and Management, pp. 219-233, (1988)
[10]  
Pressman P.I., When we would recommend prophylactic mastectomy, Prim Care Cancer, pp. 11-15, (1988)